Skip to content

Clinical trials

Giant Cell Arteritis trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Giant Cell Arteritis Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20171
20182
20192
20201
20211
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern4
Novartis Pharmaceuticals2
University Hospital, Basel, Switzerland2
AbbVie1
Bristol-Myers Squibb1
Hoffmann-La Roche1
Sanofi1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Giant Cell Arteritis13
Polymyalgia Rheumatica2
Churg-Strauss Syndrome1
Granulomatosis with Polyangiitis1
Microscopic Polyangiitis1
Polyarteritis Nodosa1
Takayasu Arteritis1
Vasculitis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.